Recent guidelines for diagnosing DKA

Reading File
Finding Sources
Searching PubMed

"diabetic ketoacidosis" AND diagnosis

Searching the Web

DKA diabetic ketoacidosis diagnosis guidelines 2024 2025 ADA

Finding Sources
Reading Article

PMID: 40032308

Reading File
Reading File
Reading Web Page

https://www.uspharmacist.com/article/managing-hyperglycemic-…

Reading File
I now have enough information from the textbooks, the 2024 ADA consensus report, and recent literature to give a thorough answer.

Diagnosing Diabetic Ketoacidosis (DKA) - 2024/2025 Guidelines

The Diagnostic Triad

The diagnosis of DKA requires all three components to be present simultaneously:
  1. Hyperglycemia (or known diabetes)
  2. Ketonemia/ketonuria
  3. Metabolic acidosis

2024 ADA Consensus Report - Key Updates

The ADA updated its consensus report on hyperglycemic crises in June 2024 (summarized in the Cleveland Clinic Journal of Medicine, 2025). The most significant changes from prior criteria are:

1. Glucose Threshold - Revised

Old Criterion2024 Updated Criterion
Blood glucose >250 mg/dLBlood glucose ≥200 mg/dL OR prior history of diabetes (regardless of glucose level)
This change formally recognizes euglycemic DKA (blood glucose <200 mg/dL), which accounts for ~10% of DKA presentations and is increasingly seen with SGLT2 inhibitor use, pregnancy, and fasting states.

2. Ketone Measurement - Beta-Hydroxybutyrate Preferred

The 2024 consensus now recommends direct measurement of venous or capillary beta-hydroxybutyrate (β-OHB) over urine ketone dipstick testing:
  • β-OHB ≥3.0 mmol/L = >90% sensitivity and specificity for DKA diagnosis
  • Urine ketones (acetoacetate) are no longer first-line because:
    • They underestimate severity early in DKA (β-OHB predominates but is not detected by urine dipstick)
    • They overestimate severity late in DKA (as β-OHB converts to acetoacetate during recovery)
Traditional threshold: urine ketones ≥2+ (if β-OHB unavailable)

3. Acidosis Criteria

  • Venous or arterial pH <7.3
  • Serum bicarbonate <18 mmol/L
  • Anion gap (Na - Cl - HCO₃) >12 mmol/L - useful but no longer the first-line diagnostic criterion; reserved for resource-limited settings where ketone measurement is unavailable
Note: Venous pH is now preferred over arterial pH - it is approximately 0.03 units lower than arterial pH, avoids arterial puncture risk, and does not change management. - Tintinalli's Emergency Medicine

Severity Classification (ADA 2024)

ParameterMildModerateSevere
Arterial pH7.25-7.307.00-7.24<7.00
Serum bicarbonate (mEq/L)15-1810-14<10
Urine ketonesPositivePositivePositive
β-OHB (mmol/L)≥3.0≥3.0≥3.0
Mental statusAlertAlert/drowsyStupor/coma

Essential Initial Workup

When DKA is suspected, the following should be obtained (Goldman-Cecil Medicine; Tintinalli's Emergency Medicine):
  • Serum glucose
  • Venous blood gas (pH, bicarbonate)
  • Serum electrolytes - calculate anion gap; note that measured serum Na is artificially low due to hyperglycemia (correction: add 2.4 mEq/L per 100 mg/dL glucose above 100 mg/dL)
  • β-hydroxybutyrate (serum or capillary) - preferred over urine ketones
  • Urine ketones - if β-OHB unavailable
  • BUN and creatinine - prerenal azotemia is common; creatinine may be falsely elevated if measured by nitroprusside-based assay
  • Serum potassium - critical before starting insulin (total body K+ is depleted even when serum K+ appears normal or high due to acidemia-driven extracellular shift)
  • CBC - leukocytosis common; WBC >25,000/mm³ or bands >10,000/mm³ suggest infection
  • ECG - assess for hyperkalemia/hypokalemia signs; also screen for ischemia as a precipitant
  • Serum osmolality - to distinguish from or identify overlap with HHS
  • Urinalysis and cultures, CXR - to identify precipitating infection

Differential Diagnosis of Elevated Anion Gap Acidosis

Conditions to distinguish from DKA (Tintinalli's):
  • Alcoholic ketoacidosis
  • Starvation ketoacidosis
  • Lactic acidosis
  • Renal failure
  • Toxic ingestions: salicylates, ethylene glycol, methanol

Key Clinical Features at Presentation

(Goldman-Cecil Medicine, p. 2484; Tintinalli's Emergency Medicine)
  • Polyuria, polydipsia, weakness, lethargy
  • Nausea, vomiting, abdominal pain (can mimic acute abdomen)
  • Kussmaul breathing (deep, rapid respirations - respiratory compensation for acidosis)
  • Fruity/acetone breath
  • Dehydration signs: dry mucous membranes, tachycardia, orthostatic hypotension
  • Altered consciousness in moderate-severe DKA

Resolution Criteria (2024 ADA)

DKA is considered resolved when ALL of:
  • Blood glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3

Special Considerations

  • Euglycemic DKA: Normal or near-normal glucose with confirmed ketonemia and acidosis. Increasingly common with SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin). Do not exclude DKA based on normal glucose alone.
  • Hyperchloremic acidosis: Can develop during treatment (from large-volume normal saline), masking true resolution - the anion gap normalizes but bicarbonate remains low. Monitor both anion gap and β-OHB during treatment.
  • Overlap with HHS: A mixed picture (ketonemia + hyperosmolality) is not uncommon, especially in type 2 diabetes with intercurrent illness. Manage per DKA protocol if significant ketonemia and acidosis are present.
  • Superimposed metabolic alkalosis (from vomiting or diuretics) can mask the true severity - an anion gap disproportionate to the bicarbonate drop should raise this suspicion.

Sources: Goldman-Cecil Medicine (2024); Tintinalli's Emergency Medicine; ADA 2024 Consensus Report summary (PMID: 40032308); US Pharmacist 2025 review
This is a shared conversation. Sign in to Orris to start your own chat.